BioSpace News Archive

WebMD Health Services today announced the launch of a new well-being solution, meQ Empower, designed to help employers create an agile, adaptive, and high-performing culture by enabling managers and leaders to build resilient and agile teams and organizations.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt hotel in New York. Zimmer Biomet will present on Wednesday, September 12, 2018 at 10:30 a.m. Eastern Time.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the European Commission has approved KEYTRUDA, the company’s anti-PD-1 therapy, in combination with pemetrexed (ALIMTA®) and platinum chemotherapy for the first-line treatment of metastatic nonsquamous non-small cell lung cancer (NSCLC) in adults whose tumors have no EGFR or ALK positive mutations.

A year after Wamberg Genomic Advisors introduced Cancer Guardian, a program that provides guidance and access to leading-edge advanced DNA testing at the time of a cancer diagnosis, the company announced that Cancer Guardian will now include enhanced Comprehensive Cancer Support.

Minnetronix, Inc. , a leading medical technology and solutions provider, today announced that it has rebranded as Minnetronix Medical, Inc.

itan Pharmaceuticals, Inc.. (NASDAQ: TTNP) today announced that it has been awarded a two year grant of approximately $6.7 million from the National Institutes of Health’s National Institute on Drug Abuse (NIDA) for the development of a ProNeura™ based six-month implantable formulation of Nalmefene, an opioid antagonist

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today announced that it has filed a Patent Cooperation Treaty (“PCT”) application pertaining to the Company’s proprietary biosynthesis program

Solis Mammography, the nation’s leader in breast imaging, is declaring September Breast Wellness Month and encouraging every woman to #DitchTheSquish with the launch of SmartCurve™ technology in its 50+ centers across the country.

Trials track plant health and yield benefits

Epilepsy Foundation Ohio Serves More than 126,000 People with Epilepsy, and their Families, in the State